ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis

by Zundelevich, Adi, Dadiani, Maya, Kahana-Edwin, Smadar, Itay, Amit, Sella, Tal, Gadot, Moran, Cesarkas, Karen, Farage-Barhom, Sarit, Saar, Efrat Glick, Eyal, Eran, Kol, Nitzan, Pavlovski, Anya, Balint-Lahat, Nora, Dick-Necula, Daniela, Barshack, Iris, Kaufman, Bella, Gal-Yam, Einav Nili
Published in Breast Cancer Res (2020)

Correction to: ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis

by Zundelevich, Adi, Dadiani, Maya, Kahana-Edwin, Smadar, Itay, Amit, Sella, Tal, Gadot, Moran, Cesarkas, Karen, Farage-Barhom, Sarit, Saar, Efrat Glick, Eyal, Eran, Kol, Nitzan, Pavlovski, Anya, Balint-Lahat, Nora, Dick-Necula, Daniela, Barshack, Iris, Kaufman, Bella, Gal-Yam, Einav Nili
Published in Breast Cancer Res (2020)

Ten-year clinical outcomes in N0 ER+ breast cancer patients with Recurrence Score-guided therapy

by Stemmer, Salomon M., Steiner, Mariana, Rizel, Shulamith, Ben-Baruch, Noa, Uziely, Beatrice, Jakubowski, Debbie M., Baron, Julie, Shak, Steven, Soussan-Gutman, Lior, Bareket-Samish, Avital, Fried, Georgeta, Rosengarten, Ora, Itay, Amit, Nisenbaum, Bella, Katz, Daniela, Leviov, Michelle, Tokar, Margarita, Liebermann, Nicky, Geffen, David B.
Published in NPJ Breast Cancer (2019)